|
|
|
Insider
Information: |
Novartis Ag |
Relationship: |
10% Owner |
City: |
Basel Switzerland |
State: |
V8 |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
49,437,478 |
|
Indirect Shares
|
22,159,174 |
|
|
Direct
Value |
$488,311,728 |
|
|
Indirect Value
|
$316,340,044 |
|
|
Total
Shares |
71,596,652 |
|
|
Total
Value |
$804,651,772 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
14
|
Stock
price went up :
|
0
|
14
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
14.0
|
Percentage
Gain/Loss : |
0.0%
|
273.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Momenta Pharmaceuticals Inc |
MNTA |
10% Owner |
|
0 |
2006-07-25 |
4,708,679 |
Premium* |
|
Adhera Therapeutics, Inc |
ATRX |
10% Owner |
2011-01-26 |
2,495,065 |
|
0 |
Premium* |
|
Idenix Pharmaceuticals Inc |
IDIX |
10% Owner |
2014-08-05 |
0 |
2014-08-05 |
0 |
Premium* |
|
Eledon Pharmaceuticals Ord Shs |
ELDN |
10% Owner |
2015-07-15 |
4,493,458 |
2014-09-22 |
0 |
Premium* |
|
Kineta Ord Shs |
KA |
10% Owner |
2016-02-17 |
1,873,791 |
2016-02-17 |
0 |
Premium* |
|
Aeglea Biotherapeutics, Inc. |
AGLE |
|
2018-05-11 |
2,175,314 |
2016-04-12 |
0 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
10% Owner |
2017-12-12 |
4,129,903 |
2016-05-11 |
0 |
Premium* |
|
Q32 Bio Inc |
QTTB |
10% Owner |
2018-04-02 |
1,979,226 |
2018-04-02 |
0 |
Premium* |
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2017-06-19 |
2,251,457 |
2016-10-31 |
0 |
Premium* |
|
Aadi Bioscience, Inc |
AADI |
10% Owner |
2017-03-15 |
0 |
2019-04-26 |
4,049,804 |
Premium* |
|
Altimmune, Inc |
ALT |
10% Owner |
|
0 |
2018-09-12 |
8,345,145 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
3,948,482 |
2018-04-23 |
0 |
Premium* |
|
Aileron Therapeutics Inc |
ALRN |
10% Owner |
2019-04-01 |
2,079,394 |
2018-07-16 |
0 |
Premium* |
|
Bicycle Therapeutics Ltd |
BCYC |
10% Owner |
2019-05-28 |
1,769,641 |
2019-05-28 |
0 |
Premium* |
|
Galera Therapeutics, Inc. |
GRTX |
Former 10% Owner |
2020-06-19 |
2,467,961 |
2019-11-12 |
3,543,067 |
Premium* |
|
Forma Therapeutics Holdings, Inc., |
FMTX |
10% Owner |
|
0 |
2020-06-18 |
331,221 |
Premium* |
|
Akouos, Inc. |
AKUS |
Former 10% Owner |
2020-06-30 |
0 |
2020-06-30 |
1,181,258 |
Premium* |
|
Poseida Therapeutics, Inc. |
PSTX |
10% Owner |
2020-07-14 |
5,908,089 |
2020-07-14 |
0 |
Premium* |
|
Cellular Biomedicine Group Inc |
CBMG |
10% Owner |
2020-08-11 |
1,458,257 |
|
0 |
Premium* |
|
Precision Biosciences Inc |
DTIL |
10% Owner |
2022-06-15 |
12,407,440 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
152 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ELDN |
Eledon Pharmaceuticals Or... |
10% Owner |
|
2015-07-15 |
4 |
S |
$14.26 |
$50,844 |
D/D |
(3,566) |
4,493,458 |
0 |
- |
|
KA |
Kineta Ord Shs |
10% Owner |
|
2016-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,498,791 |
1,498,791 |
0 |
- |
|
KA |
Kineta Ord Shs |
10% Owner |
|
2016-02-17 |
4 |
B |
$8.00 |
$3,000,000 |
D/D |
375,000 |
1,873,791 |
2.45 |
- |
|
AGLE |
Aeglea Biotherapeutics, I... |
10% Owner |
|
2016-04-12 |
4 |
B |
$10.00 |
$3,000,000 |
D/D |
300,000 |
2,310,924 |
2.45 |
- |
|
AGLE |
Aeglea Biotherapeutics, I... |
10% Owner |
|
2016-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,010,924 |
2,010,924 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
10% Owner |
|
2016-05-11 |
4 |
B |
$18.00 |
$4,999,986 |
D/D |
277,777 |
5,573,658 |
2.45 |
- |
|
NTLA |
Intellia Therapeutics, In... |
10% Owner |
|
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,295,881 |
5,295,881 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2016-10-31 |
4 |
B |
$13.00 |
$1,099,995 |
D/D |
84,615 |
2,545,652 |
2.45 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2016-10-31 |
4 |
S |
$13.00 |
$4,407 |
D/D |
(339) |
62,575 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2016-10-31 |
4 |
OE |
$0.07 |
$4,404 |
D/D |
62,914 |
62,914 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2016-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,398,462 |
2,461,037 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-02-22 |
4 |
S |
$21.86 |
$16,370 |
D/D |
(749) |
2,544,903 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-02-23 |
4 |
S |
$21.04 |
$105,160 |
D/D |
(4,999) |
2,539,904 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-02-24 |
4 |
S |
$20.93 |
$113,000 |
D/D |
(5,398) |
2,534,506 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-02-27 |
4 |
S |
$20.96 |
$1,212,306 |
D/D |
(57,844) |
2,476,662 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-02-28 |
4 |
S |
$20.86 |
$163,670 |
D/D |
(7,847) |
2,468,815 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-03-01 |
4 |
S |
$20.91 |
$162,658 |
D/D |
(7,778) |
2,461,037 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
10% Owner |
|
2017-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
79,245 |
5,652,903 |
0 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2017-03-15 |
4 |
B |
$5.00 |
$2,800,000 |
I/I |
560,000 |
5,805,550 |
1.5 |
- |
|
AADI |
Aadi Bioscience, Inc |
10% Owner |
|
2017-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,245,550 |
|
- |
|
ALT |
Altimmune, Inc |
10% Owner |
|
2017-05-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,867,301 |
|
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-05-16 |
4 |
S |
$26.33 |
$528,725 |
D/D |
(20,081) |
2,440,956 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-05-17 |
4 |
S |
$25.51 |
$574,901 |
D/D |
(22,534) |
2,418,422 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-05-18 |
4 |
S |
$25.50 |
$229,964 |
D/D |
(9,019) |
2,409,403 |
0 |
- |
|
RARX |
Ra Pharmaceuticals, Inc. |
10% Owner |
|
2017-05-24 |
4 |
S |
$25.01 |
$436,364 |
D/D |
(17,451) |
2,391,952 |
0 |
- |
|
152 Records found
|
|
Page 2 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|